Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2012
08/01/2012CN102625830A 间充质干细胞分化 Mesenchymal stem cell differentiation
08/01/2012CN102625811A FGF21 mutants and uses thereof
08/01/2012CN102625717A Bone regeneration agent including gelatin
08/01/2012CN102625712A Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same
08/01/2012CN102625711A Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides
08/01/2012CN102625710A Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates
08/01/2012CN102625709A Methods and compositions for preventing or treating ophthalmic conditions
08/01/2012CN102625708A Pi3 kinase inhibitors and uses thereof
08/01/2012CN102625707A Novel applications of HIP/PAP or derivatives thereof
08/01/2012CN102618612A Preparation method for black-bone chicken peptide for chemotherapy, attenuation and synergia and application of black-bone chicken peptide
08/01/2012CN102618565A Cytotoxic T lymphocyte-associated antigen-4, (CTLA-4) fusion protein and preparation method and application thereof
08/01/2012CN102618564A Amylases, nucleic acids encoding them and methods for making and using them
08/01/2012CN102618562A Neukinase, a downstream protein of neuregulin
08/01/2012CN102617738A Polypeptides, coding sequences, preparation method and use of recombinant fusion protein CD4-LINKER-DC-SIGN (CLD)
08/01/2012CN102617736A The new stable polyethylene glycol conjugate of interferon alpha, represented by one positional isomer
08/01/2012CN102617727A Thymalfasin compound and novel preparation method thereof
08/01/2012CN102617724A Swine alexin pBD1 polypeptide and application thereof to inhibition of swine pathogenetic fungi
08/01/2012CN102617723A Scorpion venom active peptides, preparation method thereof and application
08/01/2012CN102617722A Ancylostoma caninum anticoagulant peptide, preparation and application thereof
08/01/2012CN102617718A Bran coat antitumor active protein, as well as preparation method and applications thereof
08/01/2012CN102617708A T-cell death-inducing epitopes
08/01/2012CN102617707A New homologue 2-methyl-actinomycin D of actinomycin D and its preparation method
08/01/2012CN102617706A Methods for preventing mitochondrial permeability transition
08/01/2012CN102617705A Macrocyclic compound for suppressing replication of hepatitis c viruses
08/01/2012CN102614521A Treatment methods utilizing albumin-binding proteins as targets
08/01/2012CN102614514A GLP-1 acceptor agonists used for treating pains
08/01/2012CN102614512A Multiple-variable dose regimen for treating TNFalpha-related disorders
08/01/2012CN102614502A Application of ulinastatin to preparing anti-HIV (Human Immunodeficiency Virus)-1 virus medicament
08/01/2012CN102614501A Compound fruit protease solid preparation for preventing and treating oral diseases
08/01/2012CN102614500A Biological plant alcohol relieving and liver protecting capsule
08/01/2012CN102614499A Yak skin collagen compound traditional Tibetan medicine with anti-fatigue effect and preparation process thereof
08/01/2012CN102614498A Insulin nanoparticle and preparation method thereof
08/01/2012CN102614497A Usage of human interferon in preparation of medicines for treatment or prevention of HPV (human paillomavirus) related diseases
08/01/2012CN102614496A Wood frog bone high-calcium tablets and preparation method thereof
08/01/2012CN102614495A Application of Escherichia coli BL21 ribosomal protein subunit L36 in preparing anticancer drugs
08/01/2012CN102614494A Oral submucous fibrosis rat model construction method
08/01/2012CN102614493A Liquid pharmaceutical composition containing echinocandin antifungal agent caspofungin
08/01/2012CN102614492A Liquid pharmaceutical composition containing echinocandin antifungal agent micafungin
08/01/2012CN102614491A Pharmaceutical composition containing echinocandin antifungal agent micafungin, its preparation method and application
08/01/2012CN102614490A Co-crystals having VX-950 and pharmaceutical compositions comprising the same
08/01/2012CN102614325A Nutritional compositions and methods for treating or preventing osteoporosis
08/01/2012CN102614219A Method for preparing human prothrombin complex with high yield
08/01/2012CN102614134A Vegf拮抗剂制剂 Vegf antagonist preparations
08/01/2012CN102614125A SapC-phosphatide nano vesicle freezed-drying preparation, and preparation method and application thereof
08/01/2012CN102613567A Soybean peptide nutrient solution and preparation method and application thereof
08/01/2012CN102613453A Marine organism type enteral nutrition preparation for diabetes patients, preparation method of marine organism type enteral nutrition preparation and application
08/01/2012CN101845081B Cyclic hexapeptide antibacterial compound
08/01/2012CN101690801B Application of interleukin-1 receptor antagonist and medicinal composition thereof
08/01/2012CN101431980B Fermented product composition, cosmetic composition and method of producing the same
08/01/2012CN101272693B Process for production of fermented milk and fermented milk beverage/food
08/01/2012CN101184511B Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen
07/2012
07/31/2012US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
07/31/2012US8232373 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
07/31/2012US8232371 Modified human interferon polypeptides and their uses
07/31/2012US8232370 Antimicrobial protein specific to Staphylococcus aureus
07/31/2012US8232258 NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and variants thereof, and their use
07/31/2012US8232252 Immunoglobulin/bone morphogenic protein fusion for treatment and prevention of inflammatory disorders
07/31/2012US8232251 Compounds for delivery of therapeutic and imaging moieties to nerve cells
07/31/2012US8232250 Low frequency glatiramer acetate therapy
07/31/2012US8232248 Treatment of rheumatoid arthritis with mammal beta defensins
07/31/2012US8232247 Methods of treating cancer, arthritis and/or diabetes with angiopoietins
07/31/2012US8232246 Anti-viral compounds
07/31/2012US8232245 Caspofungin formulations
07/31/2012US8232243 Such as gonadotrophin releasing hormone, or dermorphin; use treating syndromes and disorders associated with unwanted oxidative processes in the extracellular space, including arthritis, cataracts, diabetes and artherosclerosis
07/31/2012US8232242 Treatment of inflammatory bowel diseases with mammal beta defensins
07/31/2012US8232241 Treating liver diseases
07/31/2012US8232240 Inhibitors of enveloped virus infectivity
07/31/2012US8232101 Identification of antigenic peptides from multiple myeloma cells
07/31/2012US8232075 Providing a cell culture, a culture medium of an amino acid for use in cell mass, a concentration for use in cell maintenance, and a concentration for incorporation into the polypeptide; maintaining the cell culture
07/31/2012US8232062 EGFR mutations
07/31/2012US8232053 EGFR mutations
07/31/2012US8231917 Antimicrobial peracid compositions with selected catalase enzymes and methods of use in aseptic packaging
07/31/2012US8231916 Use of a rice protein hydrolysate as pigmenting active principle
07/31/2012US8231878 Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
07/31/2012US8231874 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
07/31/2012US8231873 Methods of treatment using antibodies to Neutrokine-alpha
07/31/2012US8231870 Pharmaceutical preparation for treating benign prostatic hyperplasia
07/31/2012US8231869 Recombinant plasmin for opthalmic indications
07/31/2012US8231866 Cytokine protein family
07/31/2012CA2647158C Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto
07/31/2012CA2544374C Botulinum toxin treatments of neurological and neuropsychiatric disorders
07/31/2012CA2532913C Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain
07/31/2012CA2515505C Inhibitor for perioperative blood sugar elevation
07/31/2012CA2478409C Inhibitors of urokinase, their preparation and use
07/31/2012CA2449999C Compounds and methods for the treatment or prevention of flavivirus infections
07/31/2012CA2411919C Immunization of dairy cattle with chimeric gapc protein against streptococcus infection
07/31/2012CA2404688C Nuclear factor .kappa.b inducing factor
07/31/2012CA2370948C Growth factor homolog zvegf4
07/31/2012CA2349217C Cancer-associated antigens and methods of their identification
07/31/2012CA2348624C Adenovirus-mediated gene therapy
07/31/2012CA2341018C Polypeptides and polynucleotides from coagulase-negative staphylococci
07/31/2012CA2293736C Synthetic antibiotics
07/31/2012CA2223402C Methods of inhibiting phagocytosis
07/26/2012WO2012100234A1 Vaccines and compositions against streptococcus pneumoniae
07/26/2012WO2012100045A2 Methods of predicting response to jnk inhibitor therapy
07/26/2012WO2012100010A1 Apolipoprotein aiv as an antidiabetic peptide
07/26/2012WO2012099999A2 Methods and compositions for inducing weight loss
07/26/2012WO2012099940A2 Methods and compositions for treating ocular disease
07/26/2012WO2012099886A1 Compositions and mehthods for modulating gamma-c-cytokine activity
07/26/2012WO2012099447A2 Transgenic pig expressing stnfr1-fc genes and the use thereof
1 ... 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 ... 3163